Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 3/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.32 |
| ▸ | RELA | Q04206 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1394610 | 0.77 | MEN1 (0.35) | MAPTKMT2AKDM4EMEN1MAPK1 | |
| SCHEMBL9733032 | 0.74 | CA1 (0.40) | CA1CA2ACHEMAOACES1 | |
| SCHEMBL30252635 | 0.74 | MAOA (0.50) | CA1CA2ACHELMNASMN1; SMN2 | |
| SCHEMBL251162 | 0.74 | CA1 (0.36) | CA1CA2ACHEMAOACES1 | |
| SCHEMBL3743020 | 0.74 | CA1 (0.36) | CA1CA2ACHELMNAMAOA | |
| SCHEMBL50865 | 0.74 | MAOA (0.50) | CA1CA2ACHELMNASMN1; SMN2 | |
| SCHEMBL10702241 | 0.74 | CA1 (0.36) | CA1CA2ACHEMAOACES1 | |
| SCHEMBL2943057 | 0.74 | CA1 (0.44) | CA1CA2ACHELMNASMN1; SMN2 | |
| SCHEMBL7637856 | 0.73 | CA1 (0.43) | CA1CA2ACHELMNASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL30537100 | 0.73 | MAOA (0.48) | CA1CA2ACHELMNAMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115505099-B | Epoxy resin containing carbazole structure, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| CN-115505100-B | Epoxy resin based on spirosilafluorene as framework, and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| US-8202732-B2 | Method for analyzing activated polyethylene glycol compounds | DR. REDDY'S LABORATORIES (EU) LIMITED (GB) | 2012-06-19 | — | — | US | claimed |
| US-20120125852-A1 | METHOD FOR ANALYZING ACTIVATED POLYETHYLENE GLYCOL COMPOUNDS | DR. REDDY'S LABORATORIES (EU) LIMITED (GB) | 2012-05-24 | — | — | US | claimed |
| US-20060198818-A1 | Method for analyzing activated polyethylene glycol compounds | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2006-09-07 | — | — | US | claimed |
| EP-0569263-B1 | Balloon catheter | TERUMO CORP (JP) | 1997-07-02 | — | — | EP | claimed |
| WO-1995027288-A1 | ELECTRICALLY CONDUCTIVE PLASTIC AND METHOD FOR MAKING SAME | PERTHUISOT, OLIVIER (FR) | 1995-10-12 | — | — | WO | claimed |
| EP-0419676-B1 | THIONAPHTHALENE DERIVATIVES, METHOD OF PRODUCING THE SAME, AND ANTIALLERGIC AGENT CONTAINING THE SAME | TEIJIN LTD (JP) | 1994-12-07 | — | — | EP | claimed |
| US-5278033-A | Comprising an aldehyde heterocyclic or hydrocarbon cyclic surface tension stabilizer | KONICA CORPORATION (JP) | 1994-01-11 | — | — | US | claimed |
| EP-0569263-A2 | Balloon catheter | TERUMO KABUSHIKI KAISHA (JP) | 1993-11-10 | — | — | EP | claimed |
| EP-0419676-A1 | THIONAPHTHALENE DERIVATIVES, METHOD OF PRODUCING THE SAME, AND ANTIALLERGIC AGENT CONTAINING THE SAME | TEIJIN LIMITED (JP) | 1991-04-03 | — | — | EP | claimed |
| EP-0092971-B1 | PROCESS FOR SELECTIVELY DEPOSITING A NICKEL-BORON COATING OVER A METALLURGY PATTERN ON A DIELECTRIC SUBSTRATE AND PRODUCTS PRODUCED THEREBY | RICHARDSON CHEMICAL COMPANY (US) | 1989-08-16 | — | — | EP | claimed |
| US-4207156-A | Ultraviolet photoinitiator systems utilizing aromatic sulfides and triplet state energizers | CELANESE CORPORATION (US) | 1980-06-10 | — | — | US | claimed |
| JP-9095444-A | — | — | None | — | — | JP | disclosed |
| US-20250382406-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | FUJIFILM CORPORATION (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-4660207-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | FUJIFILM Corporation (JP) | 2025-12-10 | — | — | EP | disclosed |
| US-4246403-A | OPTICAL BRIGHTENERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4246403-A | OPTICAL BRIGHTENERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-01-20 | — | — | US | disclosed |
| US-4198422-A | Substituted 2,3-naphthimidazole carbamates and method | E. R. SQUIBB & SONS, INC. (US) | 1980-04-15 | — | — | US | disclosed |
| US-4032548-A | FROM NAPHTHALENE; VANADIUM OXIDE-SILICIC ACID-POTASSIUM SULFATE OXIDATION CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1977-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250382406-A1 | CURABLE COMPOSITION, CURED PRODUCT, OPTICAL MATERIAL, DIFFRACTIVE OPTICAL ELEMENT, AND COMPOUND | C5, Q6ZSR9, C9 | CA1 1465/4885CA2 3634/4885ACHE 1073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.